CTS Corporation Declares Cash Dividend
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 12 2026
0mins
Should l Buy CTS?
Source: Newsfilter
- Dividend Declaration: CTS Corporation's Board of Directors has declared a cash dividend of $0.04 per share, scheduled for payment on April 24, 2026, to shareholders of record as of March 27, 2025, demonstrating the company's commitment to shareholder returns.
- Shareholder Return Strategy: This dividend reflects CTS's strong cash flow and profitability, aimed at boosting investor confidence and attracting more long-term investors to the stock.
- Market Positioning: As a leading manufacturer of sensors, actuators, and electronic components, CTS serves multiple markets including aerospace/defense, industrial, medical, and transportation, showcasing its diversified business model and market adaptability.
- Global Operations: With manufacturing capabilities in North America, Europe, and Asia, CTS is well-positioned to meet global customer demands, further solidifying its leadership in technological innovation and market competition.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CTS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CTS
About CTS
CTS Corporation is a global manufacturer of sensors, connectivity components, and actuators. The Company designs, manufactures, and sells a broad line of sensors, connectivity components, and actuators primarily to original equipment manufacturers (OEMs), suppliers for the aerospace and defense, industrial, medical, and transportation markets, and the United States Government. The Company’s devices are categorized by their ability to Sense, Connect or Move. Sense products provide vital inputs to electronic systems. Connect products allow systems to function in synchronization with other systems. Move products ensure the required movements are effectively and accurately executed. Its Sense products include Controls, Pedals, Piezo Sensing Products, Sensors, Switches and Transducers. Its Connect products include EMI/RFI Filters, Capacitors, Frequency Control Products, Resistors and RF filters. The Company’s Move products include Piezo Microactuators and Rotary Actuators.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
CTS Corporation Declares Cash Dividend
- Dividend Declaration: CTS Corporation's Board of Directors has declared a cash dividend of $0.04 per share, scheduled for payment on April 24, 2026, to shareholders of record as of March 27, 2025, demonstrating the company's commitment to shareholder returns.
- Shareholder Return Strategy: This dividend reflects CTS's strong cash flow and profitability, aimed at boosting investor confidence and attracting more long-term investors to the stock.
- Market Positioning: As a leading manufacturer of sensors, actuators, and electronic components, CTS serves multiple markets including aerospace/defense, industrial, medical, and transportation, showcasing its diversified business model and market adaptability.
- Global Operations: With manufacturing capabilities in North America, Europe, and Asia, CTS is well-positioned to meet global customer demands, further solidifying its leadership in technological innovation and market competition.
See More
CTS Corporation Reports Strong Q4 2025 Earnings and 2026 Outlook
- Significant Revenue Growth: CTS Corporation reported fourth quarter sales of $137 million, reflecting a 9% year-over-year increase, with diversified market sales growing by 16%, demonstrating the successful implementation of the company's diversification strategy and strong market demand.
- Strong Medical Market Performance: The medical market saw a 41% year-over-year sales increase, highlighting robust growth momentum in therapeutic applications, which further solidifies CTS's market position in the healthcare sector.
- Margin Improvement: The adjusted gross margin for the fourth quarter reached 39.1%, up 150 basis points from the prior year, primarily driven by operational efficiencies and an improved market mix, enhancing the company's profitability.
- Optimistic 2026 Outlook: Management anticipates sales in the range of $550 million to $580 million for 2026, with adjusted EPS expected between $2.30 and $2.45, reflecting confidence in future market demand and ongoing product innovation.
See More
CTS Corporation Q4 Earnings Exceed Expectations
- Strong Earnings Performance: CTS Corporation reported a Q4 non-GAAP EPS of $0.62, beating expectations by $0.02, which reflects the company's ongoing profitability enhancement and bolsters investor confidence.
- Significant Revenue Growth: The company achieved Q4 revenue of $137.27 million, an 8.5% year-over-year increase, surpassing expectations by $1.41 million, indicating CTS's robust performance amid recovering market demand and suggesting future growth potential.
- Margin Improvement: The adjusted gross margin rose to 39.1%, up 150 basis points from 37.6% in Q4 2024, demonstrating positive progress in cost control and pricing strategies, which will help enhance overall profitability.
- Optimistic 2026 Outlook: CTS expects full-year 2026 sales to range between $550 million and $580 million, with adjusted diluted EPS projected at $2.30 to $2.45, both exceeding market consensus, showcasing the company's confidence in future performance and competitive positioning.
See More
CTS Corporation to Release Q4 and Full-Year 2025 Earnings
- Earnings Release Schedule: CTS Corporation will release its fourth quarter and full-year 2025 earnings on February 10, 2026, at 8:00 a.m. ET, providing investors with crucial financial data and performance insights.
- Conference Call Details: A conference call is scheduled for the same day at 10:00 a.m. ET, where management will discuss the earnings results, and investors can register online to receive dial-in information and conference ID, enhancing engagement with management.
- Live Webcast Availability: The conference call will feature a live audio webcast accessible directly from CTS Corporation's investor website, with the recording archived for one year, ensuring long-term availability of the information.
- Company Background: CTS Corporation is a leading designer and manufacturer of sensors, actuators, and electronic components, serving aerospace/defense, industrial, medical, and transportation markets, showcasing its broad impact and technological strength across multiple industries.
See More
CTS CEO Kieran O’Sullivan to Present at 28th Annual Needham Growth Conference
- Conference Presentation: CTS Corporation's CEO Kieran O’Sullivan is scheduled to present at the 28th Annual Needham Growth Conference on January 13, 2026, at the Lotte New York Palace Hotel, highlighting the company's advancements in sensors and electronic components.
- Live Webcast: The presentation will begin at 4:30 PM Eastern Time, allowing investors to access the live stream via the CTS website or the conference site, thereby enhancing interaction and transparency between the company and its investors.
- Replay Availability: Following the presentation, the webcast will be available for replay on the conference website for 90 days, ensuring that investors who cannot attend live can still access critical information, thus improving information accessibility.
- Company Overview: CTS Corporation specializes in designing and manufacturing sensors, actuators, and electronic components, serving various markets including aerospace, industrial, medical, and transportation, showcasing its broad capabilities in technological innovation and market application.
See More
CTS CEO Kieran O'Sullivan to Present at 28th Annual Needham Growth Conference
- Conference Presentation: CTS CEO Kieran O'Sullivan will present at the 28th Annual Needham Growth Conference on January 13, 2026, at the Lotte New York Palace Hotel, showcasing the company's advancements in sensors and electronic components.
- Live Webcast: The presentation is scheduled to begin at 4:30 PM Eastern Time, allowing investors to access the event via the CTS website or conference site, enhancing interaction and transparency between the company and its investors.
- Replay Availability: The webcast will be available for replay on the conference website for 90 days post-presentation, ensuring that investors who cannot attend live can still access critical information, thereby increasing the company's information dissemination reach.
- Company Overview: CTS is a leading manufacturer of sensors, actuators, and electronic components serving aerospace, industrial, medical, and transportation markets, demonstrating its extensive influence and technological strength in the global market.
See More
CTS Corporation Declares Cash Dividend
- Dividend Declaration: CTS Corporation's Board of Directors has declared a cash dividend of $0.04 per share, scheduled for payment on April 24, 2026, to shareholders of record as of March 27, 2025, demonstrating the company's commitment to shareholder returns.
- Shareholder Return Strategy: This dividend reflects CTS's strong cash flow and profitability, aimed at boosting investor confidence and attracting more long-term investors to the stock.
- Market Positioning: As a leading manufacturer of sensors, actuators, and electronic components, CTS serves multiple markets including aerospace/defense, industrial, medical, and transportation, showcasing its diversified business model and market adaptability.
- Global Operations: With manufacturing capabilities in North America, Europe, and Asia, CTS is well-positioned to meet global customer demands, further solidifying its leadership in technological innovation and market competition.
See More
CTS Corporation Reports Strong Q4 2025 Earnings and 2026 Outlook
- Significant Revenue Growth: CTS Corporation reported fourth quarter sales of $137 million, reflecting a 9% year-over-year increase, with diversified market sales growing by 16%, demonstrating the successful implementation of the company's diversification strategy and strong market demand.
- Strong Medical Market Performance: The medical market saw a 41% year-over-year sales increase, highlighting robust growth momentum in therapeutic applications, which further solidifies CTS's market position in the healthcare sector.
- Margin Improvement: The adjusted gross margin for the fourth quarter reached 39.1%, up 150 basis points from the prior year, primarily driven by operational efficiencies and an improved market mix, enhancing the company's profitability.
- Optimistic 2026 Outlook: Management anticipates sales in the range of $550 million to $580 million for 2026, with adjusted EPS expected between $2.30 and $2.45, reflecting confidence in future market demand and ongoing product innovation.
See More
CTS Corporation Q4 Earnings Exceed Expectations
- Strong Earnings Performance: CTS Corporation reported a Q4 non-GAAP EPS of $0.62, beating expectations by $0.02, which reflects the company's ongoing profitability enhancement and bolsters investor confidence.
- Significant Revenue Growth: The company achieved Q4 revenue of $137.27 million, an 8.5% year-over-year increase, surpassing expectations by $1.41 million, indicating CTS's robust performance amid recovering market demand and suggesting future growth potential.
- Margin Improvement: The adjusted gross margin rose to 39.1%, up 150 basis points from 37.6% in Q4 2024, demonstrating positive progress in cost control and pricing strategies, which will help enhance overall profitability.
- Optimistic 2026 Outlook: CTS expects full-year 2026 sales to range between $550 million and $580 million, with adjusted diluted EPS projected at $2.30 to $2.45, both exceeding market consensus, showcasing the company's confidence in future performance and competitive positioning.
See More
CTS Corporation to Release Q4 and Full-Year 2025 Earnings
- Earnings Release Schedule: CTS Corporation will release its fourth quarter and full-year 2025 earnings on February 10, 2026, at 8:00 a.m. ET, providing investors with crucial financial data and performance insights.
- Conference Call Details: A conference call is scheduled for the same day at 10:00 a.m. ET, where management will discuss the earnings results, and investors can register online to receive dial-in information and conference ID, enhancing engagement with management.
- Live Webcast Availability: The conference call will feature a live audio webcast accessible directly from CTS Corporation's investor website, with the recording archived for one year, ensuring long-term availability of the information.
- Company Background: CTS Corporation is a leading designer and manufacturer of sensors, actuators, and electronic components, serving aerospace/defense, industrial, medical, and transportation markets, showcasing its broad impact and technological strength across multiple industries.
See More
CTS CEO Kieran O’Sullivan to Present at 28th Annual Needham Growth Conference
- Conference Presentation: CTS Corporation's CEO Kieran O’Sullivan is scheduled to present at the 28th Annual Needham Growth Conference on January 13, 2026, at the Lotte New York Palace Hotel, highlighting the company's advancements in sensors and electronic components.
- Live Webcast: The presentation will begin at 4:30 PM Eastern Time, allowing investors to access the live stream via the CTS website or the conference site, thereby enhancing interaction and transparency between the company and its investors.
- Replay Availability: Following the presentation, the webcast will be available for replay on the conference website for 90 days, ensuring that investors who cannot attend live can still access critical information, thus improving information accessibility.
- Company Overview: CTS Corporation specializes in designing and manufacturing sensors, actuators, and electronic components, serving various markets including aerospace, industrial, medical, and transportation, showcasing its broad capabilities in technological innovation and market application.
See More
CTS CEO Kieran O'Sullivan to Present at 28th Annual Needham Growth Conference
- Conference Presentation: CTS CEO Kieran O'Sullivan will present at the 28th Annual Needham Growth Conference on January 13, 2026, at the Lotte New York Palace Hotel, showcasing the company's advancements in sensors and electronic components.
- Live Webcast: The presentation is scheduled to begin at 4:30 PM Eastern Time, allowing investors to access the event via the CTS website or conference site, enhancing interaction and transparency between the company and its investors.
- Replay Availability: The webcast will be available for replay on the conference website for 90 days post-presentation, ensuring that investors who cannot attend live can still access critical information, thereby increasing the company's information dissemination reach.
- Company Overview: CTS is a leading manufacturer of sensors, actuators, and electronic components serving aerospace, industrial, medical, and transportation markets, demonstrating its extensive influence and technological strength in the global market.
See More
